Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafoxiparin as Adjunct to Oxytocin for Slow Labor Progress
NCT03001193Phase 2Completed
- Sponsor
- Dilafor AB
- Start
- Dec 2016
- Primary completion
- Nov 2018
- Modality
- Bivalent/Multivalent Binders
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of tafoxiparin in prolonged labor (4 arms), sponsored by Dilafor AB. Primary endpoint: Time from start of infusion of tafoxiparin/placebo until vaginal partus up to 36 hours. Started Dec 2016; status: completed.
02
Drugs
tafoxiparin
03
Conditions
prolonged labor
Beyond the preview
Go deeper on NCT03001193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03001193.